Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Total Liabilities (2021 - 2025)

Medicinova (MNOV) has disclosed Total Liabilities for 7 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities changed N/A to $4.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a N/A change, with the full-year FY2025 number at $4.0 million, changed N/A from a year prior.
  • Total Liabilities was $4.0 million for Q4 2025 at Medicinova, up from $3.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $5.3 million in Q3 2022 to a low of $2.5 million in Q1 2025.
  • A 5-year average of $3.7 million and a median of $3.7 million in 2021 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: tumbled 34.4% in 2023, then increased 18.33% in 2025.
  • Medicinova's Total Liabilities stood at $3.7 million in 2021, then soared by 41.74% to $5.3 million in 2022, then dropped by 26.38% to $3.9 million in 2023, then dropped by 21.53% to $3.1 million in 2024, then surged by 31.52% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Total Liabilities are $4.0 million (Q4 2025), $3.6 million (Q3 2025), and $3.0 million (Q2 2025).